Complete Response to Nivolumab‐Relatlimab Following Progression of Invasive Sinonasal Mucosal Melanoma on First‐Line Nivolumab‐Ipilimumab: A Case Report
ABSTRACT Background Mucosal melanoma (MM) is a rare and aggressive subtype of melanoma with a notably worse prognosis than cutaneous melanoma (CM) due to its occult presentation and unique molecular profile. For advanced cases, immunotherapy has improved outcomes in recent years, although more signi...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2026-04-01
|
| Serie: | Cancer Reports |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/cnr2.70544 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|